Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Economic Experts on Managed Care

Council Members in this Study Group: 714

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

David Ziolkowski, COO/CIO, DOCTOR'S MEDICAL CENTER-SAN PABLODavid Ziolkowski

COO/CIO
DOCTOR'S MEDICAL CENTER-SAN PABLO
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Ziolkowski is COO/CIO of Doctors Medical Center in San Pablo, CA. He is responsible for all hospital operations, as well as all Hospital IT functions. Prior to that, Mr. Ziolkowski was Senior Vice President and Chief Information Officer at the Sampson Regional Medical Center in Clinton, NC. He...

Keith Berman, MPH, MBA, Consultant, HEALTH RESEARCH ASSOCIATESKeith Berman, MPH, MBA

Consultant
HEALTH RESEARCH ASSOCIATES
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Keith Berman, MPH, MBA, founded Health Research Associates in 1996. HRA provides reimbursement consulting, business development and market research services to leading biopharmaceuticals, blood products and medical device manufacturers and suppliers. Previously, Mr. Berman worked for ten years in product...

31 recent news post(s)
Richard Tarplin

Principal
Tarplin Strategies, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Richard Tarplin is the founder of Tarplin Strategies in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and health care sectors. He served for almost 20 years in the US House of Representatives and US Senate and as a senior PresidentialExecutive...

John Waugh, Director of System Laboratory Operations, HENRY FORD HEALTH SYSTEMJohn Waugh

Director of System Laboratory Operations
HENRY FORD HEALTH SYSTEM
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

John Waugh is the Director of System Laboratory Operations at Henry Ford Health System, one of the top ten US laboratories in size. In this research and academic medical center in Detroit, Mr. Waugh has expertise in new and emerging clinical and molecular diagnostic systems, including products andservices...

1 recent event(s)
Stan Schofield, MS, MHA,MT(ASCP), Managing Principal, The Compass Group, ScarboroughStan Schofield, MS, MHA,MT(ASCP)

Managing Principal
The Compass Group, Scarborough
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a Vice President and senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a...

Robert Boorstein, MD, PhD

Associate Professor, Pathology
NEW YORK UNIVERSITY (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert Boorstein, MD, PhD, is an Associate Professor in the Department of Pathology at New York University School of Medicine, where he directs clinical pathology training. Previously, Dr. Boorstein was the Director of Pathology at Bellevue Hospital and the Medical Director for Pathology and Laboratory...

17 recent news post(s)
Joseph Delaney, CPCU

Managing Partner
Hilb Rogal and Hobbs of Metropolitan Washington, Inc.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Joseph Delaney is a Managing Partner at Willis HRH of Metropolitan Washington, D.C., a brokerage which places general and specialty insurance (including property/casualty, aviation, and employee benefits) with major underwriters on behalf of its targeted clients (middle-market businesses), as wellas...

1 recent news post(s)
Ken Powell, President, Genesis Business Development, LLCKen Powell

President
Genesis Business Development, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Ken Powell is the President of Genesis Business Development, a healthcare consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of intellectual property, new businesses, and products in the clinical diagnostics and medical device market segments. He has knowledge...

196 recent news post(s)

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Will Quest Acquire Vermillion?

November 20, 2009

Ken Powell, President, Genesis Business Development, LLC

Why Quest Will Acquire Vermillion | www.genomeweb.com

Quest Diagnostics has had a known relationship with Vermillion.  Now that Vermillion has received FDA approval for its OVA1 in vitro diagnostic multi-variant index assay (IVDMIA) and Quest has an exclusive three year marketing license and a 17% investment in the company plus additional loans, acquisition...

Peplin merger with Leo pharma

November 19, 2009

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

Leo Pharma completes merger pact with Peplin | www.pharmabiz.com

The recent merger of Peplin with Leo pharma is of some significance and will benefit both companies. It would have been difficult for Peplin to fully develop and market their flagship product alone.

Roche Receives H1N1 FDA Emergency Use Authorization

November 16, 2009

Ken Powell, President, Genesis Business Development, LLC

Roche Gets FDA EUA for H1N1 Test Kit | www.genomeweb.com

Roche has received an Emergency Use Authorization from the FDA for its RealTime ready Influenza A/H1N1 Detection Set.  The new H1N1 assay is run on its MagNA Pure LC platform for nucleic acid isolation and its LightCycler 2.0 system for real-time PCR applications.  Roche, the worldwide clinical diagnostics...

Zetia Now Off Best Practices List for MI Prevention, But is Niaspan > Diet?

November 15, 2009

GLG Expert Contributor

Another Vytorin Mess For Merck | www.forbes.com

Abbott Laboratories' (ABT.N) Niaspan, though inexpensive and older, lowered HDL and shrunk artery diameter in heart patients more effectively and safely than Merck & Co's (MRK.N) moderately expensive Zetia.Though there is little reason for doctors to prescribe Zetia now, there are real cautions about...

Parkinson's Drug

November 15, 2009

GLG Expert Contributor

Oxford BioMedica Announces Update on ProSavin® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results | www.pipelinereview.com

I am happy to learn of this exciting new drug for the treatment of Parkinson's disease.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Managed Care Health Insurer, For-Profit
  • Consultancy, Healthcare-Focused
  • Office Based Private Practice or Clinic
  • Managed Care Health Insurer, Non-Profit
  • Academic Medical Center/Hospital or Clinic
  • Facility, Non-Academic/Community Hospital
  • Employee Benefits Consulting
  • Blue Cross/Blue Shield Non-Profit Health Insurer
  • Healthcare Management

Members in this Study Group often have these job titles:

  • President
  • Director
  • Chief Executive Officer
  • Principal
  • Consultant
  • Owner
  • Physician - Attending Physician
  • Pharmacist - RPh/PharmD
  • Medical Director
  • Operations Executive

Related Study Groups

Study Group Name No. Members
Managed Care Experts 669
Managed Care Pricing Trends Experts 281
Medicare Experts 493
Generic Drug Economic Experts 766
Experts on Pay-for-Performance Plans 195
Formulary Design Experts 250
Employee Benefits Experts 371

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Economic Experts on Managed Care Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Economic Experts on Managed Care have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare